Literature DB >> 23657129

Guidelines for elective percutaneous coronary intervention in patients with stable coronary artery disease (JCS 2011) published in 2012--digest version.

.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23657129     DOI： 10.1253/circj.cj-66-0065

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  12 in total

1.  SYNTAX-justified trend toward restricting coronary artery bypass grafting to more serious cases.

Authors:  Mamoru Arakawa; Atsushi Yamaguchi; Kenichi Sakakura; Homare Okamura; Junya Ako; Shin-Ichi Momomura; Hideo Adachi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-12-15

2.  STENTING STRATEGY AND FOLLOW-UP RESULTS OF MULTI-CENTER REGISTRY IN FUKUSHIMA CITY FOR LEFT MAIN CORONARY ARTERY DISEASE: BARE METAL STENT VERSUS DRUG-ELUTING STENT.

Authors:  Kazuhiko Nakazato; Hiroyuki Mizukami; Hideki Ohtake; Nobuo Sakamoto; Takayoshi Yamaki; Osamu Yamaguchi; Hiroyuki Kunii; Takayuki Ohwada; Yasuchika Takeishi
Journal:  Fukushima J Med Sci       Date:  2015-07-02

3.  Follow-up tests and outcomes for patients undergoing percutaneous coronary intervention: analysis of a Japanese administrative database.

Authors:  Tomotsugu Seki; Masato Takeuchi; Ryusuke Miki; Koji Kawakami
Journal:  Heart Vessels       Date:  2018-07-14       Impact factor: 2.037

4.  Occupational eye dose in interventional cardiology procedures.

Authors:  Yoshihiro Haga; Koichi Chida; Yuji Kaga; Masahiro Sota; Taiichiro Meguro; Masayuki Zuguchi
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

5.  The Effect of Cilostazol on Endothelial Function as Assessed by Flow-Mediated Dilation in Patients with Coronary Artery Disease.

Authors:  Hiroyoshi Mori; Atsuo Maeda; Kohei Wakabayashi; Tokutada Sato; Masahiro Sasai; Kazuma Tashiro; Yoshitaka Iso; Mio Ebato; Hiroshi Suzuki
Journal:  J Atheroscler Thromb       Date:  2016-05-09       Impact factor: 4.928

6.  Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).

Authors:  Norifumi Kawakita; Kentaro Ejiri; Toru Miyoshi; Kunihisa Kohno; Makoto Nakahama; Masayuki Doi; Mitsuru Munemasa; Masaaki Murakami; Kazufumi Nakamura; Hiroshi Ito
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

7.  Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease.

Authors:  Takayuki Ohwada; Takayuki Sakamoto; Yuki Kanno; Sayoko Yokokawa; Kazuaki Amami; Kazuhiko Nakazato; Yasuchika Takeishi; Kenichi Watanabe
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

8.  Neointimal coverage after second generation drug-eluting stent implantation has a relationship with pre-existing atherosclerotic lesion characteristics.

Authors:  Yohta Nomoto; Masashi Nakagawa; Nobuyuki Shirai; Keiko Kajio; Kazuki Mizutani; Takanori Yamazaki; Kenichi Sugioka; Kimio Kamimori; Makiko Ueda; Yasuhiro Izumiya; Minoru Yoshiyama
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 9.  Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies.

Authors:  Shaozhao Zhang; Huimin Zhou; Xiaodong Zhuang; Daya Yang; Xiuting Sun; Xiangbin Zhong; Xiaoyu Lin; Xun Hu; Yiquan Huang; Xinxue Liao; Zhimin Du
Journal:  Clin Cardiol       Date:  2019-10-14       Impact factor: 2.882

10.  Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.

Authors:  Masato Nakamura; Kazushige Kadota; Akihiko Takahashi; Junji Kanda; Hitoshi Anzai; Yasuhiro Ishii; Yoshisato Shibata; Yoshinori Yasaka; Itaru Takamisawa; Junichi Yamaguchi; Yoshihiro Takeda; Atsushi Harada; Tomoko Motohashi; Raisuke Iijima; Shiro Uemura; Yoshitaka Murakami
Journal:  J Am Heart Assoc       Date:  2020-05-12       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.